1. Home
  2. TBPH vs TRST Comparison

TBPH vs TRST Comparison

Compare TBPH & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • TRST
  • Stock Information
  • Founded
  • TBPH 2013
  • TRST 1902
  • Country
  • TBPH United States
  • TRST United States
  • Employees
  • TBPH N/A
  • TRST N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • TRST Major Banks
  • Sector
  • TBPH Health Care
  • TRST Finance
  • Exchange
  • TBPH Nasdaq
  • TRST Nasdaq
  • Market Cap
  • TBPH 464.5M
  • TRST 540.7M
  • IPO Year
  • TBPH N/A
  • TRST N/A
  • Fundamental
  • Price
  • TBPH $8.91
  • TRST $32.57
  • Analyst Decision
  • TBPH Buy
  • TRST
  • Analyst Count
  • TBPH 3
  • TRST 0
  • Target Price
  • TBPH $11.33
  • TRST N/A
  • AVG Volume (30 Days)
  • TBPH 268.3K
  • TRST 77.1K
  • Earning Date
  • TBPH 05-08-2025
  • TRST 04-21-2025
  • Dividend Yield
  • TBPH N/A
  • TRST 4.45%
  • EPS Growth
  • TBPH N/A
  • TRST N/A
  • EPS
  • TBPH N/A
  • TRST 2.68
  • Revenue
  • TBPH $65,266,000.00
  • TRST $173,999,000.00
  • Revenue This Year
  • TBPH $51.09
  • TRST $13.13
  • Revenue Next Year
  • TBPH N/A
  • TRST N/A
  • P/E Ratio
  • TBPH N/A
  • TRST $11.99
  • Revenue Growth
  • TBPH 6.11
  • TRST N/A
  • 52 Week Low
  • TBPH $7.44
  • TRST $26.14
  • 52 Week High
  • TBPH $10.90
  • TRST $38.89
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 40.95
  • TRST 67.65
  • Support Level
  • TBPH $8.69
  • TRST $31.04
  • Resistance Level
  • TBPH $10.55
  • TRST $31.80
  • Average True Range (ATR)
  • TBPH 0.38
  • TRST 0.74
  • MACD
  • TBPH -0.12
  • TRST 0.24
  • Stochastic Oscillator
  • TBPH 12.06
  • TRST 93.97

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

Share on Social Networks: